About Us

CCORN has a robust Clinical Trials program with an enthusiastic team consisting of a Principal Investigator, Sub-Investigators, a Clinical Trials Manager, and Research Associates.

The inception of the Trials program was in 2004 under the supervision of Dr. Kashyap Patel, and grew rapidly. We take pride in our Research team with over a 100 years of cumulative experience of our PIs and Sub-Is, along with extensive publications.

CCORN’s research team strives to ensure that clinical trials are conducted with the patient in mind, by careful selection of industry and academic trials that can benefit the patient in the end, by applying the highest standards of clinical and administrative procedures in each trial we conduct. To date, we have worked with more than 25 large and small hematology/oncology focused industry sponsored trials, and continue to explore for innovative ways to grow in the field.

Core team



Dr. Kashyap Patel

CEO

CEO, Carolina Blood and Cancer Care
Vice President, Community Oncology Alliance (DC)
Chairman, Biosimilars Committee (COA)
Trustee and Clinical Affairs Chair, Association of Community Cancer Centers (DC)
Medical Director, International Oncology Network
Past President, South Carolina Oncology Society (2014-2015)
Chief of Staff, Springs Memorial Hospital (2012-13)

Dr. Kashyap Patel

Our lead advisor is Dr. Kashyap Patel, who has extensive research, legislative, leadership and operational expertise in the community oncology space. He successfully co-founded a large RCM operation that started with 4 employees and now has over 1000 employees providing services to over 200 oncologists. He is the main advisor and leader with an expert panel lead.

Dr. Patel is a member of the CPC committee for the ASCO. He has been an advisor for large payers including DHHS, Palmetto GBA. He also services on the advisory board for Medical HMOs. He has a special interest in health care policy and economics and the end of life care. He recently joined ION(International Oncology Network) as a Medical Director. He has expertise in Value Based Care and has successfully led Oncology Care Model pilots with two payers including with CMMI.

Dr. Patel is the Associate Editor in Chief for the AJMC and Evidence Based Oncology. He is a certified trainer for physicians. “Education in Palliative and End of life Care: And has been a speaker at several different CME events. He is involved in healthcare economics and is working with major commercial payers on AAPM. Dr. Patel has had extensive research experience in the field of Oncology and has published and presented articles in national and international journals.

Dr. Patel has conducted over 100 CME hours’ lectures at National level on several topics including End of life Care, Biosimilars, Value Based Care, Oncology Care Model and Precision Medicine and RWE.

Dr. Asutosh Gor
Dr. Asutosh Gor

Sub Investigator

Dr. Asutosh “Bobby” Gor started his journey in medicine at Gujarat University in India before completing his residency and fellowship in New York where he was both Chief Resident and Chief Fellow. Dr. Gor has more than eight scientific publications, and is board certified in Internal Medicine, Hematology, and Medical Oncology through the American Board of Internal Medicine.

In the office, Dr. Gor can always be seen igniting smiles and laughs in patients and staff alike. Dr. Gor is an avid golfer and tennis player in his spare time.


Dr. Sashi Naidu
Dr. Sashi Naidu

Director of Clinical Trials

Dr. Sashi Naidu earned his MD from Upstate medical university before completing his residency in New Jersey and his fellowship in Pennsylvania. He participated in a variety of research experiences throughout his medical education, and now, serving as Director of Clinical Trials at Carolina Blood and Cancer Care, as well as a Primary Investigator, Dr. Naidu has overseen more than 25 clinical trials.


Dr. Niyati Nathwani
Dr. Niyati A. Nathwani

Assistant Director of Clinical Trials

Dr. Niyati A. Nathwani earned her Bachelor of Medicine and Bachelor of Surgery degree in Mumbai, India, and completed both her residency in Internal Medicine and fellowship in Hematology/Medical Oncology at USC [University of Southern California] in Los Angeles. She is licensed in California, North Carolina and South Carolina.

Dr. Nathwani has many medical publications focusing on HIV infections in women, and has served as a primary investigator (PI) on more than 15 clinical trials. She serves as the Assistant Director of Clinical Trials at Carolina Blood and Cancer Care. When she is not working, she likes traveling the world with her family.


Dr. Viral Rabara
Dr. Viral Rabara

Sub Investigator

Dr. Viral Rabara earned his MD from Medical University of Poland in 2010. Upon completion, he completed his fellowship program In Hematology/Oncology where he was a Chief Fellow from 2016-2018. Dr. Rabara has participated as a Sub-I for multiple trials and is currently a practicing Oncologist at Carolina Blood and Cancer Care and in all phased trials and registries.


Dhwani Mehta
Alpa Patel

Alpa Patel is one of the founders of CCORN. She holds BS in Psychology, and an advanced degree in law (LLB) from India. She has worked as a research coordinator for the Thomas Jefferson University Hospital, Philadelphia, and is the CFO for the Carolina Blood and Cancer Care since 2005.

Experience with Sponsors

Carolina Blood and Cancer Care’s Clinical Research Department has worked diligently with various pharmaceutical sponsors, some of which include Spectrum Pharmaceutical Inc., Amgen, Incyte Corporation, Novartis, AstraZeneca, Helsinn Healthcare SA, Asterand, Biodesix Inc., Celgene Corporation, Biocartis US Inc., and Heron Therapeutics Inc.

Click here for a list of industry Clinical Trials undertaken by our team.

Experience with EDC

Along with working with these pharmaceutical sponsors, members of the Clinical Research Department are proficient using multiple EDC systems, some of which include iMedidata, MyTrials, TrialMaster, TrialManager, and Oracle Inform.

Our expert technology team will work with our sponsors in developing a proprietary EDC software to meet the needs of the study.

How may we help? Reach Us